For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Globe Life Inc. (GL) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Globe Life Inc. is an insurance holding company that provides a broad range of life and supplemental health insurance products, along with annuities, to individuals and families in the United States. Headquartered in McKinney, Texas, the company operates through core segments that include life insurance, supplemental health insurance, and investments. Its life insurance offerings span traditional whole life, interest-sensitive whole life, and term life policies designed to provide financial protection and coverage flexibility. In health insurance, Globe Life focuses on guaranteed-renewable products such as Medicare supplement, critical illness, accident, and limited-benefit hospital and surgical coverage. The company also offers fixed-benefit annuity contracts aimed at supporting long-term financial planning needs. Globe Life distributes its products through multiple channels, including captive agencies, independent agents, and direct-to-consumer platforms, allowing it to reach a wide customer base across diverse income levels and geographies. Through its investment operations, the company manages a largely fixed-maturity portfolio structured to support policy obligations and maintain the stability of its insurance offerings in the broader financial services market.
Earnings Schedule
Checked daily · calendar updated Aug 9| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 22, 2026 | $3.68 | $3.61 -1.9% | — | — |
| Apr 22, 2026 | $3.48 | $3.43 -1.4% | — | — |
| Feb 4, 2026 | $3.44 | $3.39 -1.5% | — | — |
| Jan 14, 2026 | $0.20 | $0.18 -10.0% | — | — |
| Oct 22, 2025 | $4.54 | $4.81 +5.9% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 7, 2026 | 8-K | View |
| Aug 5, 2026 | 10-Q | View |
| Aug 5, 2026 | 144 | View |
| Aug 3, 2026 | 4 | View |
| Aug 3, 2026 | 13F-HR | View |
| Jul 30, 2026 | 4 | View |
| Jul 30, 2026 | 4 | View |
| Jul 29, 2026 | 4 | View |
| Jul 29, 2026 | 144 | View |
| Jul 27, 2026 | 144 | View |
| Jul 24, 2026 | 144 | View |
| Jul 22, 2026 | 8-K | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Last updated: Aug 9, 2026 3:39am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 14.07
Total Equity: $5.97B
Shares: 82,532,907
Total Debt: $2.63B
Cash: $144.70M
EBITDA: N/A
Total Debt: $2.63B
Cash: $144.70M
Revenue: $5.99B
Revenue: $5.99B
Revenue: $5.99B
Total Equity: $5.97B
Tax Rate: 19.1%
Equity: $5.97B
Total Debt: $2.63B
Cash: $144.70M
Current Liabilities: N/A
Long-Term Debt: $2.32B
Total Debt: $2.63B
Total Equity: $5.97B
Shares: 82,532,907
Shares: 82,532,907
CapEx: -$142.48M
Shares: 82,532,907
Stock Price: $183.85
Net Income: $1.16B
Income Statement (Annual)
Last updated: Aug 9, 2026 3:39am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.2B | $5.4B | $5.8B | $6.0B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $311.5M | $346.1M | $342.8M | $394.9M | $425.3M |
| Operating Income | — | — | — | — | — |
| Net Income | $1.0B | $894.4M | $970.8M | $1.1B | $1.2B |
| EBITDA | — | — | — | — | — |
| EPS | $7.30 | $7.55 | $10.21 | $11.99 | $14.27 |
| EPS (Diluted) | $7.22 | $7.47 | $10.07 | $11.94 | $14.07 |
Balance Sheet (Annual)
Last updated: Aug 9, 2026 3:39am (just now)| Metric | 2023 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | — | — | $103.2M | $165.3M | $144.7M |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $26.8B | $26.2B | $28.1B | $29.1B | $30.8B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | $1.6B | $2.3B | $2.3B |
| Total Liabilities | $22.8B | $21.6B | $23.6B | $23.8B | $24.8B |
| Total Equity | — | — | $4.5B | $5.3B | $6.0B |
| Retained Earnings | — | — | $7.5B | $8.0B | $8.5B |
Cash Flow (Annual)
Last updated: Aug 9, 2026 3:39am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B |
| Capital Expenditure | -$38.2M | -$27.9M | -$49.6M | -$71.0M | -$142.5M |
| Free Cash Flow | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | — | $250.5M | $170.0M | $530.0M | $0 |
| Dividends Paid | -$80.0M | -$80.5M | -$84.1M | -$85.5M | -$86.1M |
| Stock Buybacks | -$541.4M | -$454.6M | -$511.1M | -$1.0B | -$881.0M |
| Net Change in Cash | -$2.7M | $396,000 | $10.6M | $62.2M | -$20.6M |
Growth Trends (YoY %)
Last updated: Aug 9, 2026 3:39am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +2.1% | +4.2% | +6.1% | +3.7% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | -13.3% | +8.5% | +10.3% | +8.4% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 5, 2026 7:28pm (3d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-07-06 | $0.33 | — | — | — |
| 2026-04-02 | $0.33 | — | — | — |
| 2026-01-05 | $0.27 | — | — | — |
| 2025-10-03 | $0.27 | — | — | — |
| 2025-07-03 | $0.27 | — | — | — |
| 2025-04-03 | $0.27 | — | — | — |
| 2025-01-06 | $0.24 | — | — | — |
| 2024-10-04 | $0.24 | — | — | — |
| 2024-07-05 | $0.24 | — | — | — |
| 2024-04-04 | $0.24 | — | — | — |
| 2024-01-04 | $0.23 | — | — | — |
| 2023-10-05 | $0.23 | — | — | — |
| 2023-07-03 | $0.23 | — | — | — |
| 2023-03-31 | $0.23 | — | — | — |
| 2023-01-05 | $0.21 | — | — | — |
| 2022-10-06 | $0.21 | — | — | — |
| 2022-07-01 | $0.21 | — | — | — |
| 2022-04-01 | $0.21 | — | — | — |
| 2022-01-06 | $0.20 | — | — | — |
| 2021-10-01 | $0.20 | — | — | — |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-31 | Darden James Matthew | M-OptionExercise | 50,000.00 | $0.00 | $0 |
| 2026-07-31 | Darden James Matthew | S-Sale | 49,600.00 | $182.43 | $9.0M |
| 2026-07-31 | Darden James Matthew | S-Sale | 400.00 | $183.36 | $73,343 |
| 2026-07-30 | Kalmbach Thomas Peter | M-OptionExercise | 10,000.00 | $0.00 | $0 |
| 2026-07-30 | Kalmbach Thomas Peter | M-OptionExercise | 11,000.00 | $0.00 | $0 |
| 2026-07-30 | Kalmbach Thomas Peter | S-Sale | 10,720.00 | $179.30 | $1.9M |
| 2026-07-30 | Kalmbach Thomas Peter | S-Sale | 4,840.00 | $180.08 | $871,578 |
| 2026-07-30 | Kalmbach Thomas Peter | S-Sale | 2,650.00 | $181.23 | $480,255 |
| 2026-07-30 | Kalmbach Thomas Peter | S-Sale | 2,790.00 | $181.81 | $507,264 |
| 2026-07-29 | MAJORS MICHAEL CLAY | M-OptionExercise | 37,000.00 | $0.00 | $0 |
| 2026-07-29 | MAJORS MICHAEL CLAY | S-Sale | 33,500.00 | $178.56 | $6.0M |
| 2026-07-29 | MAJORS MICHAEL CLAY | S-Sale | 3,500.00 | $179.35 | $627,722 |
| 2026-07-28 | Kalmbach Thomas Peter | M-OptionExercise | 14,100.00 | $0.00 | $0 |
| 2026-07-28 | Kalmbach Thomas Peter | M-OptionExercise | 11,550.00 | $0.00 | $0 |
| 2026-07-28 | Kalmbach Thomas Peter | S-Sale | 9,550.00 | $178.06 | $1.7M |
| 2026-07-28 | Kalmbach Thomas Peter | S-Sale | 12,303.00 | $178.73 | $2.2M |
| 2026-07-28 | Kalmbach Thomas Peter | S-Sale | 3,797.00 | $179.42 | $681,246 |
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
ai-findings step) when a report is run on this ticker.
GPT Reading
gpt-critique step) after the other Big-3 seats, when a
report is run on this ticker.
Grok Reading
grok-critique step) alongside the other Big-3 seats, when a
report is run on this ticker.
Advanced Analysis Forensic deep-dive · three lenses
Character & Durability Scorecard
ext-scorecard step) when a report is run on this ticker.